The European Commission announced on Tuesday that it has initiated an antitrust investigation into Zoetis, a U.S.-based pet products manufacturer, for potentially violating EU competition laws. The investigation, announced on Tuesday, focuses on allegations that Zoetis may have engaged in practices to prevent the market launch of a competing dog pain medication. This move by the European Commission highlights the regulatory scrutiny over market practices that could hinder competition within the EU's pet care sector.